137 related articles for article (PubMed ID: 9770715)
1. [Chest X ray: routine indication in the follow-up of differentiated thyroid cancer?].
Lorenzen J; Beese M; Mester J; Brumma K; Beyer W; Clausen M
Nuklearmedizin; 1998; 37(6):208-12. PubMed ID: 9770715
[TBL] [Abstract][Full Text] [Related]
2. Is chest x-ray or high-resolution computed tomography scan of the chest sufficient investigation to detect pulmonary metastasis in pediatric differentiated thyroid cancer?
Bal CS; Kumar A; Chandra P; Dwivedi SN; Mukhopadhyaya S
Thyroid; 2004 Mar; 14(3):217-25. PubMed ID: 15072704
[TBL] [Abstract][Full Text] [Related]
3. [Metastatic differentiated thyroid cancer. Diagnostic accuracy of thyroglobulin-RIA in comparison with 131I-whole body scintigraphy].
Reiners C; Reimann J; Schäffer R; Baum K; Becker W; Eilles C; Gerhards W; Schick F; Spiegel W; Wiedemann W
Rofo; 1984 Sep; 141(3):306-13. PubMed ID: 6435198
[TBL] [Abstract][Full Text] [Related]
4. Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma.
Gallowitsch HJ; Mikosch P; Kresnik E; Unterweger O; Gomez I; Lind P
J Nucl Med; 1998 May; 39(5):870-5. PubMed ID: 9591591
[TBL] [Abstract][Full Text] [Related]
5. Iodine-131 treatment and high-resolution CT: results in patients with lung metastases from differentiated thyroid carcinoma.
Ilgan S; Karacalioglu AO; Pabuscu Y; Atac GK; Arslan N; Ozturk E; Gunalp B; Ozguven MA
Eur J Nucl Med Mol Imaging; 2004 Jun; 31(6):825-30. PubMed ID: 14762699
[TBL] [Abstract][Full Text] [Related]
6. [Contribution of computed tomography in patients with lung metastases of differentiated thyroid carcinoma not apparent on plain radiography who were treated with radioiodine].
Rosário PW; Tavares WC; Barroso AL; Rezende LL; Padrão EL; Purisch S
Arq Bras Endocrinol Metabol; 2008 Feb; 52(1):114-9. PubMed ID: 18345404
[TBL] [Abstract][Full Text] [Related]
7. Role of initial iodine-131 whole-body scan and serum thyroglobulin in differentiated thyroid carcinoma metastases.
Filesi M; Signore A; Ventroni G; Melacrinis FF; Ronga G
J Nucl Med; 1998 Sep; 39(9):1542-6. PubMed ID: 9744339
[TBL] [Abstract][Full Text] [Related]
8. Papillary thyroid cancer with chest metastases only detected using radioactive iodine.
Kuo SF; Chen ST; Kao PF; Chang YC; Chou SC; Lin JD
Chang Gung Med J; 2004 Sep; 27(9):663-72. PubMed ID: 15605906
[TBL] [Abstract][Full Text] [Related]
9. [131I-accumulating pulmonary and bone metastases of differentiated thyroid cancer with low serum thyroglobulin levels--an exception in tumor follow-up?].
Arning G; Ehrenheim C; Schober O; Hundeshagen H
Nuklearmedizin; 1987 Jun; 26(3):139-42. PubMed ID: 3628022
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of technetium-99m methoxyisobutyl isonitrile (99mTc-MIBI) scintigraphy in detecting thyroid cancer metastases: a critical evaluation.
Alam MS; Kasagi K; Misaki T; Miyamoto S; Iwata M; Iida Y; Konishi J
Thyroid; 1998 Dec; 8(12):1091-100. PubMed ID: 9920363
[TBL] [Abstract][Full Text] [Related]
11. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy.
Lind P; Gallowitsch HJ
Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519
[TBL] [Abstract][Full Text] [Related]
12. 131-I treatment of micronodular pulmonary metastases from papillary thyroid carcinoma.
Sisson JC; Giordano TJ; Jamadar DA; Kazerooni EA; Shapiro B; Gross MD; Zempel SA; Spaulding SA
Cancer; 1996 Nov; 78(10):2184-92. PubMed ID: 8918413
[TBL] [Abstract][Full Text] [Related]
13. Follow-up of differentiated thyroid cancer: what is the value of FDG and sestamibi in the diagnostic algorithm?
Dietlein M; Scheidhauer K; Voth E; Theissen P; Schicha H
Nuklearmedizin; 1998 Jan; 37(1):12-7. PubMed ID: 9467164
[TBL] [Abstract][Full Text] [Related]
14. Metastatic papillary thyroid carcinoma with normal serum thyroglobulin level.
Miller JH; Marcus CS
Clin Nucl Med; 1988 Sep; 13(9):652-3. PubMed ID: 3180613
[TBL] [Abstract][Full Text] [Related]
15. [Thyroglobulin, 131I-whole body scintigraphy and risk factors in the follow-up of differentiated thyroid cancer].
Berding G; Hüfner M; Georgi P
Nuklearmedizin; 1992 Feb; 31(1):32-7. PubMed ID: 1561118
[TBL] [Abstract][Full Text] [Related]
16. Role of chest radiography in the diagnosis and follow-up of pulmonary metastasis in differentiated thyroid cancer.
Somboonporn C; Simthamnimit P; Puttharak W; Tumsatan P; Ngamjarus C; Roysri K
J Med Assoc Thai; 2010 Mar; 93 Suppl 3():S52-60. PubMed ID: 21299092
[TBL] [Abstract][Full Text] [Related]
17. Can iodine-131 whole-body scan be replaced by thyroglobulin measurement in the post-surgical follow-up of differentiated thyroid carcinoma?
Ronga G; Fiorentino A; Paserio E; Signore A; Todino V; Tummarello MA; Filesi M; Baschieri I
J Nucl Med; 1990 Nov; 31(11):1766-71. PubMed ID: 2121913
[TBL] [Abstract][Full Text] [Related]
18. Technetium-99m-tetrofosmin whole-body scintigraphy in the follow-up of differentiated thyroid carcinoma.
Lind P; Gallowitsch HJ; Langsteger W; Kresnik E; Mikosch P; Gomez I
J Nucl Med; 1997 Mar; 38(3):348-52. PubMed ID: 9074515
[TBL] [Abstract][Full Text] [Related]
19. Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan.
Chung JK; So Y; Lee JS; Choi CW; Lim SM; Lee DS; Hong SW; Youn YK; Lee MC; Cho BY
J Nucl Med; 1999 Jun; 40(6):986-92. PubMed ID: 10452315
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic whole-body scanning before radioiodine therapy for pulmonary metastases of differentiated thyroid cancer: predictive value and recommendations.
Tachi Y; Iwano S; Kato K; Tadokoro M; Naganawa S
Clin Nucl Med; 2008 Dec; 33(12):845-51. PubMed ID: 19033784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
